Univariate and multifactorial regression analyses from the validation group similarly demonstrated that ANXA1 could be an independent prognostic factor for predicting prognosis in ES patients (P<0.001) (Figure 1E, 1F). Here, ANXA1 is linked to Ewing sarcoma.